| pubmed-article:16075415 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16075415 | lifeskim:mentions | umls-concept:C0017889 | lld:lifeskim |
| pubmed-article:16075415 | lifeskim:mentions | umls-concept:C0031716 | lld:lifeskim |
| pubmed-article:16075415 | lifeskim:mentions | umls-concept:C0868955 | lld:lifeskim |
| pubmed-article:16075415 | lifeskim:mentions | umls-concept:C0877853 | lld:lifeskim |
| pubmed-article:16075415 | lifeskim:mentions | umls-concept:C1553628 | lld:lifeskim |
| pubmed-article:16075415 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:16075415 | pubmed:dateCreated | 2005-10-31 | lld:pubmed |
| pubmed-article:16075415 | pubmed:abstractText | Choline and the related compounds phosphocholine (PC) and glycerophosphocholine (GPC) are considered to be important metabolites in oncology. Past studies have demonstrated correlations linking the relative ratios and concentrations of these metabolites with the development and progression of cancer. Currently, in vivo and tissue ex vivo magnetic resonance spectroscopy methods have mostly centered on measuring the total concentration of these metabolites and have difficulty in differentiating between them. Here, a new scheme that uses (31)P edited (1)H spectroscopy to quantify the concentrations of choline, PC and GPC in biological samples is reported and its applicability is demonstrated using samples of human brain tumor extracts. This method is particularly well-suited for analytical situations where the PC and GPC resonances are not sufficiently resolved and/or are obscured by other metabolites. Consequently, this scheme has the potential to be used for the analysis of choline compounds in ex vivo tissue samples. | lld:pubmed |
| pubmed-article:16075415 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16075415 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16075415 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16075415 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16075415 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16075415 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16075415 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16075415 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16075415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16075415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16075415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16075415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16075415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16075415 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16075415 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:16075415 | pubmed:issn | 0952-3480 | lld:pubmed |
| pubmed-article:16075415 | pubmed:author | pubmed-author:GonzalezR... | lld:pubmed |
| pubmed-article:16075415 | pubmed:author | pubmed-author:LoeningNikola... | lld:pubmed |
| pubmed-article:16075415 | pubmed:author | pubmed-author:ChengLeo LLL | lld:pubmed |
| pubmed-article:16075415 | pubmed:author | pubmed-author:ZepedaAndrea... | lld:pubmed |
| pubmed-article:16075415 | pubmed:author | pubmed-author:ChamberlinAnn... | lld:pubmed |
| pubmed-article:16075415 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16075415 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:16075415 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16075415 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16075415 | pubmed:pagination | 413-20 | lld:pubmed |
| pubmed-article:16075415 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:16075415 | pubmed:meshHeading | pubmed-meshheading:16075415... | lld:pubmed |
| pubmed-article:16075415 | pubmed:meshHeading | pubmed-meshheading:16075415... | lld:pubmed |
| pubmed-article:16075415 | pubmed:meshHeading | pubmed-meshheading:16075415... | lld:pubmed |
| pubmed-article:16075415 | pubmed:meshHeading | pubmed-meshheading:16075415... | lld:pubmed |
| pubmed-article:16075415 | pubmed:meshHeading | pubmed-meshheading:16075415... | lld:pubmed |
| pubmed-article:16075415 | pubmed:meshHeading | pubmed-meshheading:16075415... | lld:pubmed |
| pubmed-article:16075415 | pubmed:meshHeading | pubmed-meshheading:16075415... | lld:pubmed |
| pubmed-article:16075415 | pubmed:meshHeading | pubmed-meshheading:16075415... | lld:pubmed |
| pubmed-article:16075415 | pubmed:meshHeading | pubmed-meshheading:16075415... | lld:pubmed |
| pubmed-article:16075415 | pubmed:meshHeading | pubmed-meshheading:16075415... | lld:pubmed |
| pubmed-article:16075415 | pubmed:meshHeading | pubmed-meshheading:16075415... | lld:pubmed |
| pubmed-article:16075415 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16075415 | pubmed:articleTitle | Quantification of phosphocholine and glycerophosphocholine with 31P edited 1H NMR spectroscopy. | lld:pubmed |
| pubmed-article:16075415 | pubmed:affiliation | Department of Chemistry, Lewis & Clark College, Portland, OR 97219, USA. loening@lclark.edu | lld:pubmed |
| pubmed-article:16075415 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16075415 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16075415 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16075415 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16075415 | lld:pubmed |
